O'SHAUGHNESSY ASSET MANAGEMENT, LLC

Position in EXEL — Exelixis, Inc.

CIK 1423442 Stamford, CT

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,785,416

+$1,215,464 QoQ

Shares Held

124,709

-4.0% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#150

of 754 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

O'SHAUGHNESSY ASSET MANAGEMENT, LLC holds $102,425,978 across 44 Biotechnology names. EXEL ranks #4 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	42,063	$20,893,953
2	AUPH	Aurinia Pharmaceuticals Inc.	567,492	$9,630,339
3	PBYI	Puma Biotechnology, Inc.	1,123,783	$9,113,880
4	EXEL	Exelixis, Inc. This page	124,709	$6,785,416
5	JAZZ	Jazz Pharmaceuticals plc	25,864	$6,232,448
6	ARGX	Argenx SE	6,450	$5,984,116
7	REGN	Regeneron Pharmaceuticals, Inc.	9,404	$5,863,770
8	RIGL	Rigel Pharmaceuticals Inc	131,177	$5,131,644

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,785,416	124,709	-4.0%	Shares	Sole	2026-08-13
2026-03-31	$5,569,952	129,866	+1.2%	Shares	Sole	2026-05-13
2025-12-31	$5,621,986	128,268	-2.8%	Shares	Sole	2026-02-11
2025-09-30	$5,451,021	131,986	+16.5%	Shares	Sole	2025-11-13
2025-06-30	$4,992,324	113,256	+216.4%	Shares	Sole	2025-08-12
2025-03-31	$1,321,588	35,796	+269.8%	Shares	Sole	2025-05-13
2024-12-31	$322,310	9,679	+8.5%	Shares	Sole	2025-02-12
2024-09-30	$231,422	8,918	+6050.3%	Shares	Sole	2024-11-12
2021-09-30	$3,065	145	+49.5%	Shares	Sole	2021-11-10
2021-06-30	$1,767	97	-44.6%	Shares	Sole	2021-08-09
2021-03-31	$3,953	175	+52.2%	Shares	Sole	2021-05-14
2020-12-31	$2,308	115	-94.7%	Shares	Sole	2021-02-11
2020-09-30	$53,252	2,178	-11.4%	Shares	Sole	2020-11-12
2020-06-30	$58,352	2,458	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.